Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Verstockt

Showing results (41-50 of 167) with videos related to

Pageof 17
Sort By:
Gut|March 1, 2020
Big data in IBD: big progress for clinical practiceNasim Sadat Seyed Tabib, Matthew Madgwick, Padhmanand Sudhakar, et al.
Journal of Crohn'S & Colitis|January 28, 2023
Patient-reported Outcomes and Disability Are Associated with Histological Disease Activity in Patients with Ulcerative Colitis: Results from the APOLLO StudyBram Verstockt, Lieven Pouillon, Florence Ballaux, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 20, 2026
Intestinal Barrier Dysfunction in Chronic Kidney Disease: Evidence, Mechanisms, and its Potential Clinical ImplicationsWard Zadora, Elisabeth Jacobs, Mara Lauriola, et al.
United European Gastroenterology Journal|July 19, 2019
Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseasesClaire Liefferinckx, Bram Verstockt, Ann Gils, et al.
Frontiers in Immunology|April 1, 2021
Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling PathwaysMarileen M Prins, Bram Verstockt, Marc Ferrante, et al.
Journal of Crohn'S & Colitis|March 17, 2021
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to TherapyBram Verstockt, Nurulamin M Noor, Urko M Marigorta, et al.
Updates in Surgery|June 12, 2023
Effect of anastomotic configuration on Crohn's disease recurrence after primary ileocolic resection: a comparative monocentric study of end-to-end versus side-to-side anastomosisGabriele Bislenghi, Peter-Jan Vancoillie, Steffen Fieuws, et al.
Iscience|April 28, 2022
Integrated analysis of microbe-host interactions in Crohn's disease reveals potential mechanisms of microbial proteins on host gene expressionPadhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, et al.
Journal of Crohn'S & Colitis|January 6, 2025
Radiation exposure in patients with inflammatory bowel diseaseThibaud Jorissen, Liselotte Fierens, Hilde Bosmans, et al.
Inflammatory Bowel Diseases|February 17, 2024
Crohn's Patient Serum Proteomics Reveals Response Signature for Infliximab but not VedolizumabCarlos G Gonzalez, Toer W Stevens, Bram Verstockt, et al.
Pageof 17

Showing results (41-50 of 167) with videos related to

Sort By:
Pageof 17
Gut|March 1, 2020
Big data in IBD: big progress for clinical practiceNasim Sadat Seyed Tabib, Matthew Madgwick, Padhmanand Sudhakar, et al.
Journal of Crohn'S & Colitis|January 28, 2023
Patient-reported Outcomes and Disability Are Associated with Histological Disease Activity in Patients with Ulcerative Colitis: Results from the APOLLO StudyBram Verstockt, Lieven Pouillon, Florence Ballaux, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 20, 2026
Intestinal Barrier Dysfunction in Chronic Kidney Disease: Evidence, Mechanisms, and its Potential Clinical ImplicationsWard Zadora, Elisabeth Jacobs, Mara Lauriola, et al.
United European Gastroenterology Journal|July 19, 2019
Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseasesClaire Liefferinckx, Bram Verstockt, Ann Gils, et al.
Frontiers in Immunology|April 1, 2021
Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling PathwaysMarileen M Prins, Bram Verstockt, Marc Ferrante, et al.
Journal of Crohn'S & Colitis|March 17, 2021
Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to TherapyBram Verstockt, Nurulamin M Noor, Urko M Marigorta, et al.
Updates in Surgery|June 12, 2023
Effect of anastomotic configuration on Crohn's disease recurrence after primary ileocolic resection: a comparative monocentric study of end-to-end versus side-to-side anastomosisGabriele Bislenghi, Peter-Jan Vancoillie, Steffen Fieuws, et al.
Iscience|April 28, 2022
Integrated analysis of microbe-host interactions in Crohn's disease reveals potential mechanisms of microbial proteins on host gene expressionPadhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, et al.
Journal of Crohn'S & Colitis|January 6, 2025
Radiation exposure in patients with inflammatory bowel diseaseThibaud Jorissen, Liselotte Fierens, Hilde Bosmans, et al.
Inflammatory Bowel Diseases|February 17, 2024
Crohn's Patient Serum Proteomics Reveals Response Signature for Infliximab but not VedolizumabCarlos G Gonzalez, Toer W Stevens, Bram Verstockt, et al.
Pageof 17